Your search returned 8 results.

Results
	1.	Response to the comments from Drs Shimazawa and Ikeda. [electronic resource] by Shah, Rashmi R Shah, Devron R Producer: 20131001 In: British journal of clinical pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Personalized medicine: is it a pharmacogenetic mirage? [electronic resource] by Shah, Rashmi R Shah, Devron R Producer: 20130204 In: British journal of clinical pharmacology vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology. [electronic resource] by Shah, Rashmi R Shah, Devron R Producer: 20190627 In: Drug safety vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives. [electronic resource] by Shah, Rashmi R Morganroth, Joel Shah, Devron R Producer: 20140130 In: Drug safety vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy. [electronic resource] by Shah, Devron R Shah, Rashmi R Morganroth, Joel Producer: 20131023 In: Drug safety vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients. [electronic resource] by Shah, Devron R Dholakia, Shamik Shah, Rashmi R Producer: 20150330 In: Drug safety vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval). [electronic resource] by Shah, Rashmi R Morganroth, Joel Shah, Devron R Producer: 20140204 In: Drug safety vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	A fresh perspective on comparing the FDA and the CHMP/EMA: approval of antineoplastic tyrosine kinase inhibitors. [electronic resource] by Shah, Rashmi R Roberts, Samantha A Shah, Devron R Producer: 20140502 In: British journal of clinical pharmacology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)